Cochrane Austria, Danube University Krems, Krems an der Donau, Austria, and RTI International, Research Triangle Park, North Carolina (G.G.).
Cochrane Austria, Danube University Krems, Krems an der Donau, Austria (G.W., L.A., A.C., A.D., I.K., A.K.).
Ann Intern Med. 2021 Jul;174(7):967-976. doi: 10.7326/M20-5504. Epub 2021 Apr 27.
Dyspnea is a common and often debilitating symptom with a complex diagnostic work-up.
To evaluate the benefits, harms, and diagnostic test accuracy of point-of-care ultrasonography (POCUS) in patients with acute dyspnea. (PROSPERO: CRD42019126419).
Searches of multiple electronic databases without language limitations (January 2004 to August 2020) and reference lists of pertinent articles and reviews.
Five randomized controlled trials (RCTs) and 44 prospective cohort-type studies in patients with acute dyspnea evaluated POCUS as a diagnostic tool to determine the underlying cause of dyspnea. Two investigators independently screened the literature for inclusion.
Data abstraction by a single investigator was confirmed by a second investigator; 2 investigators independently rated risk of bias and determined certainty of evidence.
Point-of-care ultrasonography, when added to a standard diagnostic pathway, led to statistically significantly more correct diagnoses in patients with dyspnea than the standard diagnostic pathway alone. In-hospital mortality and length of hospital stay did not differ significantly between patients who did or did not receive POCUS in addition to standard diagnostic tests. Finally, POCUS consistently improved the sensitivities of standard diagnostic pathways to detect congestive heart failure, pneumonia, pulmonary embolism, pleural effusion, or pneumothorax; specificities increased in most but not all studies.
Most studies assessed diagnostic test accuracy, which has limited utility for clinical decision making. Studies rarely reported on the proportion of indeterminate sonography results, and no evidence is available on adverse health outcomes of false-positive or false-negative POCUS results.
Point-of-care ultrasonography can improve the correctness of diagnosis in patients with acute dyspnea.
American College of Physicians.
呼吸困难是一种常见且常使人虚弱的症状,其诊断过程复杂。
评估即时超声检查(POCUS)在急性呼吸困难患者中的获益、危害和诊断测试准确性。(PROSPERO:CRD42019126419)。
无语言限制的多个电子数据库检索(2004 年 1 月至 2020 年 8 月),以及相关文章和综述的参考文献列表。
五项随机对照试验(RCT)和 44 项急性呼吸困难患者的前瞻性队列研究评估了 POCUS 作为一种诊断工具,以确定呼吸困难的潜在原因。两名研究者独立筛选文献以纳入研究。
由一名研究者进行的数据提取,由另一名研究者进行确认;两名研究者独立评估偏倚风险并确定证据的确定性。
与单独使用标准诊断途径相比,POCUS 可使呼吸困难患者的诊断正确率显著提高。在接受或不接受 POCUS 加标准诊断测试的患者之间,住院死亡率和住院时间无显著差异。最后,POCUS 一致提高了标准诊断途径检测充血性心力衰竭、肺炎、肺栓塞、胸腔积液或气胸的敏感性;在大多数但不是所有研究中,特异性均有所提高。
大多数研究评估了诊断测试准确性,这对临床决策的实用性有限。研究很少报告不确定超声结果的比例,也没有关于假阳性或假阴性 POCUS 结果对健康不良后果的证据。
POCUS 可提高急性呼吸困难患者的诊断正确性。
美国医师学院。